[Skip to Content]
[Skip to Content Landing]
Citations 0
Quick Uptakes
October 28, 1998

Shutting Down Hepatitis C . . .

Author Affiliations

Not Available

Not Available

JAMA. 1998;280(16):1393. doi:10.1001/jama.280.16.1393-JQU80007-3-1

Higher daily doses of interferon alpha may be more effective than standard treatment for patients with hepatitis C, according to a new study.

Researchers at the University of Illinois at Chicago (UIC) and collaborators elsewhere have reported that, in a group of 23 patients with hepatitis C, daily doses of 10 million or 15 million units for 2 weeks were the most effective in decreasing viral load. The standard treatment approach is 3 million units of interferon three times a week.

First Page Preview View Large
First page PDF preview
First page PDF preview